BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11999799)

  • 1. The toxicology of the three commercial polybrominated diphenyl oxide (ether) flame retardants.
    Hardy ML
    Chemosphere; 2002 Feb; 46(5):757-77. PubMed ID: 11999799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal oral (gavage) developmental toxicity study of decabromodiphenyl oxide in rats.
    Hardy ML; Schroeder R; Biesemeier J; Manor O
    Int J Toxicol; 2002; 21(2):83-91. PubMed ID: 12022634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the properties of the major commercial PBDPO/PBDE product to those of major PBB and PCB products.
    Hardy ML
    Chemosphere; 2002 Feb; 46(5):717-28. PubMed ID: 11999795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicokinetics of BDE 47 in female mice: effect of dose, route of exposure, and time.
    Staskal DF; Diliberto JJ; DeVito MJ; Birnbaum LS
    Toxicol Sci; 2005 Feb; 83(2):215-23. PubMed ID: 15509665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro dermal absorption of flame retardant chemicals.
    Hughes MF; Edwards BC; Mitchell CT; Bhooshan B
    Food Chem Toxicol; 2001 Dec; 39(12):1263-70. PubMed ID: 11696400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicology of octabromobiphenyl and decabromodiphenyl oxide.
    Norris JM; Kociba RJ; Schwetz BA; Rose JQ; Humiston CG; Jewett GL; Gehring PJ; Mailhes JB
    Environ Health Perspect; 1975 Jun; 11():153-61. PubMed ID: 126149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A brominated flame retardant, 2,2',4,4',5-pentabromodiphenyl ether: uptake, retention, and induction of neurobehavioral alterations in mice during a critical phase of neonatal brain development.
    Eriksson P; Viberg H; Jakobsson E; Orn U; Fredriksson A
    Toxicol Sci; 2002 May; 67(1):98-103. PubMed ID: 11961221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polybrominated biphenyl and diphenylether flame retardants: analysis, toxicity, and environmental occurrence.
    Pijnenburg AM; Everts JW; de Boer J; Boon JP
    Rev Environ Contam Toxicol; 1995; 141():1-26. PubMed ID: 7886253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma PBDE and thyroxine levels in rats exposed to Bromkal or BDE-47.
    Darnerud PO; Aune M; Larsson L; Hallgren S
    Chemosphere; 2007 Apr; 67(9):S386-92. PubMed ID: 17257644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decabromodiphenyl oxide.
    IARC Monogr Eval Carcinog Risks Hum; 1990; 48():73-84. PubMed ID: 2197464
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential effects of polybrominated diphenyl ethers and polychlorinated biphenyls on [3H]arachidonic acid release in rat cerebellar granule neurons.
    Kodavanti PR; Derr-Yellin EC
    Toxicol Sci; 2002 Aug; 68(2):451-7. PubMed ID: 12151641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobehavioral effects of decabromodiphenyl ether (Deca) in neonatal mice.
    Hardy ML
    Toxicol Sci; 2004 Oct; 81(2):528-9. PubMed ID: 15359078
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxic effects of brominated flame retardants in man and in wildlife.
    Darnerud PO
    Environ Int; 2003 Sep; 29(6):841-53. PubMed ID: 12850100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal exposure of the male mouse to 2,2',3,3',4,4',5,5',6,6'-decabrominated diphenyl ether: decreased epididymal sperm functions without alterations in DNA content and histology in testis.
    Tseng LH; Lee CW; Pan MH; Tsai SS; Li MH; Chen JR; Lay JJ; Hsu PC
    Toxicology; 2006 Jul; 224(1-2):33-43. PubMed ID: 16713668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarifications on PBDE flame retardants.
    Rothenbacher K
    Environ Sci Technol; 2003 Jul; 37(13):238A. PubMed ID: 12875373
    [No Abstract]   [Full Text] [Related]  

  • 16. Workplace environmental exposure level guide: decabromodiphenyl oxide.
    Am Ind Hyg Assoc J; 1981 Apr; 42(4):A76-7. PubMed ID: 7234684
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability and mass balance studies of a commercial pentabromodiphenyl ether mixture in male Sprague-Dawley rats.
    Huwe J; Hakk H; Lorentzsen M
    Chemosphere; 2007 Jan; 66(2):259-66. PubMed ID: 16814363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 28-day oral dose toxicity study in Wistar rats enhanced to detect endocrine effects of decabromodiphenyl ether (decaBDE).
    Van der Ven LT; van de Kuil T; Leonards PE; Slob W; Cantón RF; Germer S; Visser TJ; Litens S; Håkansson H; Schrenk D; van den Berg M; Piersma AH; Vos JG; Opperhuizen A
    Toxicol Lett; 2008 Jun; 179(1):6-14. PubMed ID: 18495385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity of the pentabrominated diphenyl ether mixture, DE-71, and hexabromocyclododecane (HBCD) in rat cerebellar granule cells in vitro.
    Reistad T; Fonnum F; Mariussen E
    Arch Toxicol; 2006 Nov; 80(11):785-96. PubMed ID: 16614824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobehavioral derangements in adult mice receiving decabrominated diphenyl ether (PBDE 209) during a defined period of neonatal brain development.
    Viberg H; Fredriksson A; Jakobsson E; Orn U; Eriksson P
    Toxicol Sci; 2003 Nov; 76(1):112-20. PubMed ID: 12915714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.